APP and Parkinson disease: Traditionally, basic and clinical research focused on the disease-defining proteins HTT in HD, Abeta and Tau in AD and α-synuclein in PD, respectively, to reveal underlying mechanism of pathogenic protein aggregation and its impact on initiation and progression of disease.